scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding scPharmaceuticals Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 16.2M | 15.9M | −293.0K (−1.8%) |
| Value | $107.9M | $80.0M | −$27.9M (−25.9%) |
New holders (5)
Institutions that held scPharmaceuticals Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Thomasville National Bank | 15,000 | $75.0K | 0.01% |
| IPG Investment Advisors LLC | 14,300 | $72.0K | 0.01% |
| Sandy Cove Advisors, LLC | 10,592 | $53.0K | 0.04% |
| Simplex Trading, LLC | 539 | $2.00K | 0.00% |
| JPMorgan Chase & Co | 14 | $0 | 0.00% |
Sold out (3)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ergoteles LLC | 27,116 | $180.0K |
| HRT Financial LP | 16,189 | $107.0K |
| Barclays PLC | 814 | $5.00K |